406 related articles for article (PubMed ID: 10507772)
1. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
4. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
5. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
Zhang T; Lai Q; Du D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
[TBL] [Abstract][Full Text] [Related]
6. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
7. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
8. [Expression of nm23-H1 gene in oral squamous cell carcinoma and its relation to tumor metastasis].
Zhang T; Lai Q; Du D; Zhao Y; Chai J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):19-24. PubMed ID: 12569635
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
11. [The effects of nm23-H1 on metastases ability and chemo-sensitivity in Tca8113 cell lines].
Chen S; Huang H; Pan J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Jun; 21(3):180-3. PubMed ID: 12898755
[TBL] [Abstract][Full Text] [Related]
12. nm23-H1 protein expression in anal canal carcinoma: does it correlate with prognosis?
Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; Limiti MR; Ghini C; Vecchione A
J Surg Oncol; 2000 Jun; 74(2):163-6. PubMed ID: 10914829
[TBL] [Abstract][Full Text] [Related]
13. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
15. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
17. Immunohistologic detection of nm23-H1 protein in squamous cell carcinoma of the vulva.
Hantschmann P; Beysiegel S; Assemi C; Kurzl R
J Reprod Med; 2004 Oct; 49(10):787-95. PubMed ID: 15568401
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
